Literature DB >> 23345231

Central amygdala GluA1 facilitates associative learning of opioid reward.

You-Qing Cai1, Wei Wang, Yuan-Yuan Hou, Zhi Zhang, Jun Xie, Zhizhong Z Pan.   

Abstract

GluA1 subunits of AMPA glutamate receptors are implicated in the synaptic plasticity induced by drugs of abuse for behaviors of drug addiction, but GluA1 roles in emotional learning and memories of drug reward in the development of drug addiction remain unclear. In this study of the central nucleus of the amygdala (CeA), which is critical in emotional learning of drug reward, we investigated how adaptive changes in the expression of GluA1 subunits affected the learning process of opioid-induced context-reward association (associative learning) for the acquisition of reward-related behavior. In CeA neurons, we found that CeA GluA1 expression was significantly increased 2 h after conditioning treatment with morphine, but not 24 h after the conditioning when the behavior of conditioned place reference (CPP) was fully established in rats. Adenoviral overexpression of GluA1 subunits in CeA accelerated associative learning, as shown by reduced minimum time of morphine conditioning required for CPP acquisition and by facilitated CPP extinction through extinction training with no morphine involved. Adenoviral shRNA-mediated downregulation of CeA GluA1 produced opposite effects, inhibiting the processes of both CPP acquisition and CPP extinction. Adenoviral knockdown of CeA GluA2 subunits facilitated CPP acquisition, but did not alter CPP extinction. Whole-cell recording revealed enhanced electrophysiological properties of postsynaptic GluA2-lacking AMPA receptors in adenoviral GluA1-infected CeA neurons. These results suggest that increased GluA1 expression of CeA AMPA receptors facilitates the associative learning of context-drug reward, an important process in both development and relapse of drug-seeking behaviors in drug addiction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23345231      PMCID: PMC3711547          DOI: 10.1523/JNEUROSCI.1749-12.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  67 in total

1.  NMDA receptor hypofunction in the prelimbic cortex increases sensitivity to the rewarding properties of opiates via dopaminergic and amygdalar substrates.

Authors:  Stephanie F Bishop; Nicole M Lauzon; Melanie Bechard; Shervin Gholizadeh; Steven R Laviolette
Journal:  Cereb Cortex       Date:  2010-04-14       Impact factor: 5.357

2.  PKMζ maintains drug reward and aversion memory in the basolateral amygdala and extinction memory in the infralimbic cortex.

Authors:  Ying-Ying He; Yan-Xue Xue; Ji-Shi Wang; Qin Fang; Jian-Feng Liu; Li-Fen Xue; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2011-06-01       Impact factor: 7.853

Review 3.  AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future.

Authors:  M Scott Bowers; Billy T Chen; Antonello Bonci
Journal:  Neuron       Date:  2010-07-15       Impact factor: 17.173

4.  Reinforcement-related regulation of AMPA glutamate receptor subunits in the ventral tegmental area enhances motivation for cocaine.

Authors:  Kwang Ho Choi; Scott Edwards; Danielle L Graham; Erin B Larson; Kimberly N Whisler; Diana Simmons; Allyson K Friedman; Jessica J Walsh; Zia Rahman; Lisa M Monteggia; Amelia J Eisch; Rachael L Neve; Eric J Nestler; Ming-Hu Han; David W Self
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

5.  Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference.

Authors:  Ameneh Rezayof; Maryam Sardari; Mohammad-Reza Zarrindast; Touraj Nayer-Nouri
Journal:  Behav Brain Res       Date:  2011-01-22       Impact factor: 3.332

6.  The activation of NMDA receptor-ERK pathway in the central amygdala is required for the expression of morphine-conditioned place preference in the rat.

Authors:  Fang Li; Xiao-Sheng Wang; Ru-Ping Dai; Jian-Yi Zhang; Xin-Fu Zhou; Wei Hao; Chang-Qi Li
Journal:  Neurotox Res       Date:  2011-06-17       Impact factor: 3.911

7.  Amygdala circuitry mediating reversible and bidirectional control of anxiety.

Authors:  Kay M Tye; Rohit Prakash; Sung-Yon Kim; Lief E Fenno; Logan Grosenick; Hosniya Zarabi; Kimberly R Thompson; Viviana Gradinaru; Charu Ramakrishnan; Karl Deisseroth
Journal:  Nature       Date:  2011-03-09       Impact factor: 49.962

8.  Increased insertion of glutamate receptor 2-lacking alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors at hippocampal synapses upon repeated morphine administration.

Authors:  Sophie K Billa; Jie Liu; Nicole L Bjorklund; Namita Sinha; Yu Fu; Patricia Shinnick-Gallagher; Jose A Morón
Journal:  Mol Pharmacol       Date:  2010-02-16       Impact factor: 4.436

9.  Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking.

Authors:  Garret D Stuber; Dennis R Sparta; Alice M Stamatakis; Wieke A van Leeuwen; Juanita E Hardjoprajitno; Saemi Cho; Kay M Tye; Kimberly A Kempadoo; Feng Zhang; Karl Deisseroth; Antonello Bonci
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

10.  Epigenetic suppression of GAD65 expression mediates persistent pain.

Authors:  Zhi Zhang; You-Qing Cai; Fang Zou; Bihua Bie; Zhizhong Z Pan
Journal:  Nat Med       Date:  2011-10-09       Impact factor: 53.440

View more
  16 in total

Review 1.  Amygdala pain mechanisms.

Authors:  Volker Neugebauer
Journal:  Handb Exp Pharmacol       Date:  2015

2.  Brain Circuits Mediating Opposing Effects on Emotion and Pain.

Authors:  You-Qing Cai; Wei Wang; Adriana Paulucci-Holthauzen; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2018-06-25       Impact factor: 6.167

3.  PARP-1 is required for retrieval of cocaine-associated memory by binding to the promoter of a novel gene encoding a putative transposase inhibitor.

Authors:  E Lax; A Friedman; R Massart; R Barnea; L Abraham; D Cheishvili; M Zada; H Ahdoot; T Bareli; G Warhaftig; L Visochek; M Suderman; M Cohen-Armon; M Szyf; G Yadid
Journal:  Mol Psychiatry       Date:  2016-09-06       Impact factor: 15.992

4.  Persistent pain maintains morphine-seeking behavior after morphine withdrawal through reduced MeCP2 repression of GluA1 in rat central amygdala.

Authors:  Yuan-Yuan Hou; You-Qing Cai; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

5.  MeCP2 repression of G9a in regulation of pain and morphine reward.

Authors:  Zhi Zhang; Wenjuan Tao; Yuan-Yuan Hou; Wei Wang; Paul J Kenny; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2014-07-02       Impact factor: 6.167

6.  Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats.

Authors:  Shayla E Russell; Daniel J Puttick; Allison M Sawyer; David N Potter; Stephen Mague; William A Carlezon; Elena H Chartoff
Journal:  J Neurosci       Date:  2016-05-25       Impact factor: 6.167

7.  GluA1 in Central Amygdala Promotes Opioid Use and Reverses Inhibitory Effect of Pain.

Authors:  Yuan-Yuan Hou; You-Qing Cai; Zhizhong Z Pan
Journal:  Neuroscience       Date:  2019-12-19       Impact factor: 3.590

Review 8.  Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction.

Authors:  Jasper A Heinsbroek; Taco J De Vries; Jamie Peters
Journal:  Cold Spring Harb Perspect Med       Date:  2021-03-01       Impact factor: 6.915

9.  Acute nicotine administration increases BOLD fMRI signal in brain regions involved in reward signaling and compulsive drug intake in rats.

Authors:  Adrie W Bruijnzeel; Jon C Alexander; Pablo D Perez; Rayna Bauzo-Rodriguez; Gabrielle Hall; Rachel Klausner; Valerie Guerra; Huadong Zeng; Moe Igari; Marcelo Febo
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

10.  Bidirectional Modulation of Extinction of Drug Seeking by Deep Brain Stimulation of the Ventral Striatum.

Authors:  Freddyson J Martínez-Rivera; Jose Rodriguez-Romaguera; Mario E Lloret-Torres; Fabricio H Do Monte; Gregory J Quirk; Jennifer L Barreto-Estrada
Journal:  Biol Psychiatry       Date:  2016-05-27       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.